G E Gendlin Selected Research

G E Gendlin Research Topics

4	Atrial Fibrillation 04/2022 - 01/2013
3	Heart Failure 01/2020 - 01/2017
2	Hypertension (High Blood Pressure) 04/2022 - 01/2007
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2017
2	Neoplasms (Cancer) 03/2019 - 01/2017
2	Stroke (Strokes) 01/2017 - 01/2013
2	Pulmonary Hypertension 01/2017 - 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2022
1	Respiratory Insufficiency (Respiratory Failure) 10/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020
1	Atrioventricular Block 03/2019
1	Hodgkin Disease (Hodgkin's Disease) 03/2019
1	Angina Pectoris 03/2019
1	Myocardial Infarction 03/2019
1	Cardiotoxicity 01/2017
1	Pulmonary Arterial Hypertension 01/2017
1	Pericarditis 01/2017
1	Pulmonary Embolism 01/2017
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2017
1	Left Ventricular Dysfunction 01/2017
1	Hemorrhagic Stroke 01/2015
1	Ischemic Stroke 01/2013
1	Hypertrophy 01/2009
1	Chronic Renal Insufficiency 01/2007
1	Proteinuria 01/2007
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2007
1	Anemia 01/2007

3	AnticoagulantsIBA 04/2022 - 01/2013
1	ibrutinibIBA 04/2022
1	TroponinIBA 10/2021
1	Deoxycytidine Monophosphate (DCMP)IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	AnthracyclinesIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2015
1	Warfarin (Coumadin)FDA LinkGeneric 01/2013
1	C-Reactive ProteinIBA 01/2007
1	AlbuminsIBA 01/2007
1	Phosphorus (Red Phosphorus)IBA 01/2007